SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039743
Filing Date
2023-11-07
Accepted
2023-11-07 16:10:40
Documents
14
Period of Report
2023-11-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45971
2 ex10-1.htm EX-10.1 269341
3 ex99-1.htm EX-99.1 15904
  Complete submission text file 0001493152-23-039743.txt   552329

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE thar-20231103.xsd EX-101.SCH 3030
5 XBRL LABEL FILE thar-20231103_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE thar-20231103_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3407
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Tharimmune, Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 231383813
SIC: 2834 Pharmaceutical Preparations